Clinical, Immunological and Molecular Characteristics of 37 Iranian Patients with X-Linked Agammaglobulinemia
Authors:
- Asghar AghamohammadiAAAsghar Aghamohammadi
- Maurilia FioriniMFMaurilia Fiorini
- Mostafa MoinMMMostafa Moin
- Nima ParvanehNPNima Parvaneh
- Shahram TeimourianSTShahram Teimourian
- Mehdi YeganehMYMehdi Yeganeh
- Francesca GoffiFGFrancesca Goffi
- Hirokazu KaneganeHKHirokazu Kanegane
- Ali Akbar AmirzargarAAAli Akbar Amirzargar
- Zahra PourpakZPZahra Pourpak
- Nima RezaeiNRNima Rezaei
- Ali SalavatiASAli Salavati
- 1 November 2006
- journal article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 141 (4) , 408-414
Abstract
Background: X-linked agammaglobulinemia (XLA) is a hereditary immunodeficiency characterized by an early onset of recurrent bacterial infections, a profound deficiency of all immunoglobulin isotypes and a markedly reduced number of peripheral B lymphocytes. Eighty-five percent of the patients with this phenotype have mutations in Bruton’s tyrosine kinase (BTK) gene. Methods: To provide an informative outlook of clinical and immunological manifestations of XLA in Iran, 37 Iranian male patients with an age range of 1–34 years, followed over a period of 25 years, were studied. Twenty-four of the 37 patients were screened for BTK gene mutation using PCR-SSCP followed by direct sequencing. BTK protein expression assay was done by flow cytometry in 9 families. Results: All patients first presented with infectious diseases, the most common of which were respiratory tract infections. Eighteen different mutations were identified, 13 of which were novel: IVS1+5G>C, 1896G>A, 349delA, 1618C>T, 1783T>C, 2084A>G, 1346delT, 1351delGAG, 587A>G, IVS14–1G>A, IVS3+2T>C, 1482G>A, 1975C>A. Conclusion: The fact that we found a great number of novel mutations in a relatively limited number of patients underlines the heterogeneity of BTK mutations in the Iranian population. The large number of new mutations indicates that extended studies in this region would be rewarding.Keywords
This publication has 33 references indexed in Scilit:
- Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profilingImmunological Reviews, 2005
- BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemiaHuman Mutation, 2004
- Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemiaHuman Mutation, 2002
- Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemiaHuman Mutation, 2001
- Mutations in Btk in Patients with Presumed X-Linked AgammaglobulinemiaThe American Journal of Human Genetics, 1998
- Mutations in the Human λ5/14.1 Gene Result in B Cell Deficiency and AgammaglobulinemiaJournal of Experimental Medicine, 1998
- X-Linked Agammaglobulinemia A Clinical and Molecular AnalysisMedicine, 1996
- Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID MiceScience, 1993
- Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 1993
- X-Linked AgammaglobulinemiaMedicine, 1985